Influence of tumor volume on survival in patients irradiated for non—small-cell lung cancer
Authors:
- Lawrence B MarksLMLawrence B Marks
- Su-Min ZhouSZSu-Min Zhou
- Gunilla C BentelGBGunilla C Bentel
- Robert CloughRCRobert Clough
- Maria L HernandoMHMaria L Hernando
- Pehr A LindPLPehr A Lind
- 1 July 2002
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 53 (4) , 835-846
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I TrialJournal of Clinical Oncology, 2001
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinomaCancer, 1998
- Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trialThe Lancet, 1997
- Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 TrialJNCI: Journal of the National Cancer Institute, 1996
- Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90-15Cancer, 1995
- Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1995
- Cancer statistics, 1992CA: A Cancer Journal for Clinicians, 1992
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 PatientsJNCI: Journal of the National Cancer Institute, 1991